CL
RVMDW icon

CSS LLC’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

CSS LLC’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$282K Sell
17,505
-1,940
-10% -$3.76K 0.01% 673
2025
Q4 		$164K Hold
19,445
– – 0.01% 791
2025
Q3 		$52.4K Sell
19,445
-16,402
-46% -$3.98K ﹤0.01% 899
2025
Q2 		$84.7K Sell
35,847
-15,541
-30% -$2.31K ﹤0.01% 849
2025
Q1 		$17.6K Buy
51,388
+25,120
+96% +$3.12K ﹤0.01% 871
2024
Q4 		$42.5K Buy
26,268
+9,607
+58% +$2.84K ﹤0.01% 901
2024
Q3 		$21K Buy
16,661
+1,658
+11% +$202 ﹤0.01% 777
2024
Q2 		$13.8K Buy
15,003
+147
+1% +$30 ﹤0.01% 831
2024
Q1 		$24.4K Buy
14,856
+2,975
+25% +$602 ﹤0.01% 757
2023
Q4 		$35.3K Buy
+11,881
New +$5.31K ﹤0.01% 733

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

CSS LLC's RVMDW Position: Q1 2026 in Review

CSS LLC reduced its Revolution Medicines Inc Warrant (RVMDW) stake by 10% in Q1 2026, selling an estimated $3.76K and leaving 17,505 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #673.

CSS LLC first reported a position in RVMDW in Q4 2023 and has held it in 10 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • CSS LLC held 17,505 shares of Revolution Medicines Inc Warrant worth $282K as of Q1 2026.
  • CSS LLC sold 1,940 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $3.76K.
  • Revolution Medicines Inc Warrant made up 0.01% of CSS LLC's portfolio in Q1 2026, its #673 holding.
  • CSS LLC first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 10 quarters since.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.